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CHANGES OF SOME INDEXES
OF HOMEOSTASIS AND OF HISTOLOGY
OF PLACENTAS IN WOMEN WITH THE
THREAT OF MISCARRIAGE IN EARLY
TERMS OF PREGNANCY
Purpose. This study investigates the role of pregnancy-related proteins in
pathogenesis of the threat of abortion in the 1st trimester of pregnancy in
relation to the changes of hemostasis and histological changes of
postpartum placenta. Design/methodology/approach. 30 women with
uncomplicated course of pregnancy and 96 patients with the signs of the
threat of abortion in the 1st trimester of pregnancy have been examined.
The serum levels of pregnancy-specific beta-glycoprotein-1 (PSG1) and
progestagen-associated endometrial protein (PAEP, placental protein 14)
have been studied, as well as serum levels of the hormones (estradiol,
progesterone, cortisol) and indexes of hemostasis. The extract of ginkgo
and erynithum have been used in the therapeutic complex for treatment of
the threat of abortion. The histological research of the postpartum
placentas has been performed. The study uses the primary data.
Findings. The conclusion has been made that these medications improve
functioning of trophoblast in the 1st trimester, and PSG1 and PAEP are the
main factors which prevent development of the disorders of hemostasis in
case of the threat of abortion. According to histological research, the
proposed therapeutic complex is thought to increase compensatory
reaction of the placental tissue in response to hypoxia. Originality/value.
This study researches the changes in the placental proteins, hormones
and the parameters of blood coagulation in pregnant women in the
context of threat of abortion in the 1st pregnancy trimester in combination
with histological examination of postpartum placentas.
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Introduction
The problem of miscarriage and spontaneous abortion
is one of the most important in modern obstetrics. The
frequency of cases of miscarriage in Ukraine is 15-23% of
all fixated pregnancy cases [3], and it has no tendency to
decreasing ³ íå ìàº òåíäåíö³¿ äî çíèæåííÿ. The immune
and vascular adaptation is considered to be basic in
pregnancy process. The transformation of spiral arteries
takes place during pregnancy: the cells of endothelium are
replaced by trophoblastic cells, and the non-striated
muscular cells are replaced by matrix, cells of trophoblast
and fibrin [2, 5]. Insufficient invasion of the trophoblast in
area of placental site results in occlusion of spiral and
uterine-placental arteries what can lead to spontaneous
abortion in early term of gestation or placental dysfunction
in later pregnancy terms. If the pregnancy has been
complicated by the threat of abortion, the average
frequency of neonatal asphyxia rises up to 17,5% [7].
Aim of study
To investigate the role of pregnancy-related proteins
in pathogenesis of the threat of abortion in the 1st trimester
of pregnancy in relation to the changes of hemostasis and
histological changes of postpartum placenta.
Materials and methods
96 pregnant females with the clinical signs of the
threat of abortion in 1st pregnancy trimester have
been selected in the main study group. The clinical
signs included: pain in the lower abdomen, spot-like
bloody discharge from vagina, ultrasound signs of
the threatened abortion (segmental uterine contrac-
tions). Patients with known severe extragenital
pathology, verified cervical incompetence, AB0 and
Rh-immunization and TORCH-infections were not
included in the group. 30 healthy pregnant women
formed control group.
The main study group has been divided into two
equal subgroups: 48 patients formed subgroup with
traditional treatment of miscarriage, so they
received pregnancy-saving complex therapy [1,4],
including hormonal treatment (Duphaston 20-40 mg/
day), spasmolytics, sedative and hemostatic medi-
cations. Other 48 women, who formed subgroup of
20
Êë³í³÷íà òà åêñïåðèìåíòàëüíà ïàòîëîã³ÿ Òîì XII,  ¹3 (45), 2013
correction additionally were treated by our thera-
peutic complex which included extract of ginkgo (in
40 mg capsules 3 times daily) and erynithum (10 mg
pills 3 times daily). Extract of ginkgo has the
disaggregant properties meanwhile erynithum is the
donor of nitric oxide (NO). The course of treatment
(excluding Duphaston) was 10-12 days and had been
prescribed since 6th-8th weeks of pregnancy. The
course of treatment had been repeated 3 times with
the intervals of 7-10 days. The proposed therapy was
aimed to improve blood supply for trophoblast.
25 pregnant randomly selected women from the
subgroup of correction were examined using
methods described below [1]. The levels of the
hormones (estradiol, progesterone, cortisol) were
investigated in the venous blood by radio-immune
analysis using automatic diagnostic complex
“Gamma-1” and its specific chemical reagents
(manufactured in Minsk, Republik of Belarus).
Concentrations of pregnancy-specific beta-
glycoprotein-1 (PSG1) and progestagen-associated
endometrial protein (PAEP, placental protein 14)
were studied using diagnostic sets specific for those
proteins (manufactured by “ÄÈÀ-Ì” company,
Russia). The changes in hemostasis were established
basing on the next indexes: recalcification time (RT),
prothrombin time (PT), thrombin time (TT), quantity
of platelets in 1 ml, percent of adhesive thrombocytes
(PAT) and index of spontaneous aggregation of
thrombocytes (ISAT).
Such extent of examinations was conducted
twice: in 6-8 and 12-13 weeks of pregnancy. The
blood samples were taken at the morning on fasting
conditions of patients. The comparison was
performed with the results of 24 randomly selected
patients from subgroup with traditional treatment and
with all 30 patients from control group.
Results of study and their discussion
The serum levels of the hormones in examined
women are represented in Table 1.
As seen from the table, the serum level of cortisol
is significantly higher in both subgroups with threat
of abortion, in comparison with healthy pregnant
women (p<0,05). The mean concentration of
estradiol in subgroup of correction was higher than
in control group in 6-8 weeks of pregnancy with the
background of treatment, and in 12-13 weeks of
gestation (p<0,05). It might be caused by
compensatory increasing of synthetic function of the
trophoblast/placenta. The changes of concentration
of the progesterone in the blood of pregnant with
threat of miscarriage attract the most attention. The
mean concentration of this hormone in subgroup of
correction was the lowest by the start of treatment,
but at 12th-13th week of gestation it had no significant
difference with similar index of control group but
was higher in comparison with such index of group
with traditional treatment (p<0,05).
The results of studying of the concentrations of
the placental proteins are represented in Table 2.
It has been established that the mean
concentration of PSG1 in both subgroups with
complicated pregnancy is significantly lower than in
control group (ð<0,05). It is true for 6-8 and 12-13
weeks of gestation. The level of PSG1 was higher in
subgroup of correction than in subgroup with
traditional treatment by the end of the 1st trimester
(ð<0,05). Concerning PAEP it was unveiled that the
mean level of this protein at 12th-13th week of
pregnancy was higher both in subgroup of correction
and control group, comparing with subgroup with
traditional treatment (p<0,05).
The parameters of coagulation in women with the
clinical signs of threatened abortion are represented
in Table 3.
As seen from Table 3, time of re-calcification,
prothrombin time and thrombin time are shortened at
the end of the 1st pregnancy trimester in subgroup
with traditional treatment in comparison with control
group (p<0,05). In the subgroup of correction the
coagulation indexes at 12th – 13th weeks of pregnancy
get closer to the results of the control group. The
mean concentration of fibrinogen had no significant
differences between groups. Obviously, the received
data is an evidence of appearance of the tendency to
hypercoagulation which accompanies the clinic of
threatened abortion during the 1st trimester of
gestation.
The results of examination of the thrombocyte-
related hemostasis are represented in the Table 4.
We found the signs of the tension of the
thrombocyte-related hemostasis in women with
complicated course of pregnancy. It manifests in
increased count of the thrombocytes per 1 ml and in
activation of membrane potential of the
thrombocytes (seen as higher PAT and ISAT) in
comparison with control group (ð<0,05). At the same
time, this component of hemostasis is normalized on
the background of proposed treatment. For instance,
the mean PAT and ISAT and count of thrombocytes
are lower in the subgroup of correction than in
subgroup with traditional treatment (ð<0,05);
moreover, PAT is even lower than in the control
(ð<0,05). Such changes, according to our opinion,
lead to improvement of the blood supply of the
trophoblast.
The proposed complex of treatment improves the
integration between different systems of the
organism which are responsible for normal
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development of the fetal egg. It is confirmed by
comparative analysis of the correlations between
indexes which characterize different factors of
pathogenesis of the threat of abortion in women of
examined groups. For example, in patients with
pregnancy course complicated by threat of abortion
we unveiled the next correlations between protein-
synthesizing and hormonal sections of adaptation:
the index of PSG1 has the direct correlation with
level of cortisol (ã=0,63, ð<0,05) at the 12th – 13th
weeks of pregnancy; the  level of PAEP in 12-13
gestational weeks was negatively linked with
concentration of progesterone measured in 6-8 weeks
of pregnancy (ã= -0,56, ð<0,05). Studying the
integration between protein-synthesizing function of
the trophoblast/placenta and system of hemostasis
we’ve established that concentration of PSG1 has the
negative correlation with the count of the
thrombocytes per 1 ml (ã= -0,50, ð<0,05), with PAT
(ã= -0,58, ð<0,05) and with ISAT (ã= -0,60, ð<0,05).
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In addition, the level of PAEP measured in 12-13 weeks
of pregnancy has the negative correlation with the count
of the thrombocytes per 1 ml (ã= -0,55, ð<0,05) and
PAT (ã=-0,50, ð<0,05). Cortisol is considered to have
the strongest influence on the thrombocyte-related
hemostasis among the studied hormones. Its level had
the negative correlation with the count of the
thrombocytes per 1 ml (ã= -0,52, ð<0,05) and PAT (ã=
-0,57, ð<0,05) in 12-13 weeks of pregnancy.
After completion of pregnancy the pathohistologic
examination of postpartum placenta has been
conducted. It was performed in all 48 women from
subgroup of correction and in 42 women from subgroup
with traditional treatment. 6 women  (12,504,77%)
from subgroup of traditional treatment had spontaneous
abortions in pregnancy term 14-21 weeks.  Changes of
placental histology (table 5) were studied according to
criteria of placental insufficiency by A.Milovanov [5].
It has been established that in women who
received our therapeutic complex, thickening of the
syncytium-capillary membranes was seen signifi-
cantly less commonly (p<0,05). At the same time,
vascular hyperplasia and accumulation of the
syncytial proliferative “nodes” were found more
frequently in placentas of women in subgroup of
correction (p<0,05). The mentioned signs are thought
to be histological markers of compensatory reaction
of the placental tissue due to hypoxia [5]. To put in
sum, the diagnosis of placental insufficiency based
on histological changes had been established in 13
cases (27,08±6,41%) from the subgroup of
correction and in 27 cases (64,297,39%) from the
subgroup with traditional treatment (p<0,05).
Conclusions
1. The proposed complex of treatment of the threat
of abortion in the 1st trimester of pregnancy leads to
improvement of the function of the trophoblast at the
12th – 13th weeks of pregnancy. It manifests in
significant increasing of the serum levels of
progesterone, PSG1 and PAEP, in comparison with
patients who received traditional therapy, as well as in
normalization of the parameters of hemostasis.
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2. Pregnancy-specific beta-glycoprotein-1 (PSG1)
and progestagen-associated endometrial protein
(PAEP) are the main factors of suppression of the pro-
coagulant mechanisms (especially, activation of the
thrombocytes) in case of the threatened abortion at the
1st trimester of gestation. Progressive decreasing of the
serum concentrations of the mentioned proteins is
linked with the dysfunction of placenta which is
forming. In our opinion, it can cause appearance of
more severe disorders in the system of regulation of
aggregation of the blood, what might lead to
impairment of the blood supply of the fetal egg.
3. Histological signs of placental insufficiency are
seen less commonly in placentas of women who had
the threat of miscarriage at the 1st pregnancy tri-
mester and received proposed therapeutic complex,
in comparison with women with traditional
treatment. The proposed therapeutic complex is
thought to increase compensatory reaction of the
placental tissue in response to hypoxia.
Prospective of the further studies
The further studies provide the investigations of
the levels of the PSG1 and PAEP in later pregnancy
terms, as well as studying of the link between the
levels of the mentioned proteins and condition of the
newborns.
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ÇÌ²ÍÈ ÄÅßÊÈÕ ÏÎÊÀÇÍÈÊ²Â ÃÎÌÅÎÑÒÀÇÓ ÒÀ
Ã²ÑÒÎËÎÃ²×Í² ÇÌ²ÍÈ ÏËÀÖÅÍÒ Ó Æ²ÍÎÊ ²Ç
ÇÀÃÐÎÇÎÞ ÂÈÊÈÄÍß Ó ÐÀÍÍ² ÒÅÐÌ²ÍÈ
ÃÅÑÒÀÖ²¯
À.Ì. Áåðáåöü, Î.À. Àíäð³ºöü, ².Ð. Í³öîâè÷
Ìåòà äîñë³äæåííÿ. Âèâ÷èòè çíà÷åííÿ ïëàöåíòàðíèõ
á³ëê³â â ïàòîãåíåç³ çàãðîçè âèêèäíÿ â ² òðèìåñòð³ âàã³òíîñò³
òà ¿õ çâ’ÿçîê ç ñèñòåìîþ ãåìîñòàçó òà ïàòîã³ñòîëîã³÷íèìè
çì³íàìè â ï³ñëÿïîëîãîâèõ ïëàöåíòàõ.
Äèçàéí äîñë³äæåííÿ. Îáñòåæåíî 30 æ³íîê ³ç íåóñêëàä-
íåíèì ïåðåá³ãîì âàã³òíîñò³ (êîíòðîëüíà ãðóïà) òà 96 æ³íîê
ç îçíàêàìè çàãðîçè íåâèíîøóâàííÿ â ² òðèìåñòð³ (îñíîâíà
ãðóïà). Âèâ÷àëèñÿ ñèðîâàòêîâ³ ð³âí³ á³ëê³â âàã³òíîñò³ (òðî-
ôîáëàñòè÷íîãî â-ãë³êîïðîòå¿íó - ÒÁÃ, á-2-ì³êðîãëîáóë³íó
ôåðòèëüíîñò³ - ÀÌÃÔ), ãîðìîí³â êðîâ³ (åñòðàä³îëó, ïðîãåñ-
òåðîíó, êîðòèçîëó) òà ïîêàçíèêè ãåìîñòàçó. Äëÿ ë³êóâàííÿ
íåâèíîøóâàííÿ âèêîðèñòîâóâàëè â ñêëàä³ òåðàïåâòè÷íîãî
êîìïëåêñó åêñòðàêò ã³íêãî á³ëîáà òà åðèí³ò. Ïðîâåäåíî ïàòî-
ã³ñòîëîã³÷íå äîñë³äæåííÿ ïëàöåíò ï³ñëÿ ïîëîã³â. Â äîñë³ä-
æåíí³ âèêîðèñòàíî ïåðâèíí³ äàí³.
Ðåçóëüòàòè. Åêñòðàêò ã³íêãî á³ëîáà òà åðèí³ò ïîêðàùó-
þòü ôóíêö³þ òðîôîáëàñòà â ² òðèìåñòð³, à ÒÁÃ òà ÀÌÃÔ º
ãîëîâíèìè ÷èííèêàìè, ùî ïåðåøêîäæàþòü ðîçâèòêó ïîðó-
øåíü ó ñèñòåì³ ãåìîñòàçó ïðè íåâèíîøóâàíí³. Çã³äíî ðåçóëü-
òàò³â ïàòîã³ñòîëîã³¿, çàïðîïîíîâàíèé òåðàïåâòè÷íèé êîìï-
ëåêñ çá³ëüøóº êîìïåíñàòîðíó ðåàêö³þ ïëàöåíòàðíî¿ òêàíè-
íè ó â³äïîâ³äü íà ã³ïîêñ³þ.
Íîâèçíà. Âèâ÷àþòüñÿ çì³íè ð³âí³â ïëàöåíòàðíèõ á³ëê³â,
ãîðìîí³â òà ïàðàìåòð³â ãåìîñòàçó ó âàã³òíèõ â êîíòåêñò³ çàã-
ðîçè âèêèäíÿ â ² òðèìåñòð³ â ïîºäíàíí³ ç ïàòîã³ñòîëîã³÷íèì
äîñë³äæåííÿì ïëàöåíò ï³ñëÿ ïîëîã³â.
Êëþ÷îâ³ ñëîâà: çàãðîçà âèêèäíÿ, òðîôîáëàñò, ïëàöåíòà,
òðîôîáëàñòè÷íèé áåòà-1-ãë³êîïðîòå¿í, àëüôà-2-ì³êðîãëî-
áóë³í ôåðòèëüíîñò³, ãîðìîíè, ãåìîñòàç, ã³ñòîëîã³ÿ, åêñòðàêò
ã³íêãî á³ëîáà, åðèí³ò.
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ÃÅÑÒÀÖÈÈ
À.Í. Áåðáåö, Î.À. Àíäðèåö, È.Ð. Íèöîâè÷
Öåëü èññëåäîâàíèÿ. Èçó÷èòü çíà÷åíèå áåëêîâ áåðåìåí-
íîñòè â ïàòîãåíåçå óãðîçû âûêèäûøà â I òðèìåñòðå ãåñòàöèè
è èõ ñâÿçü ñ ñèñòåìîé ãåìîñòàçà è ïàòîãèñòîëîãè÷åñêèìè
èçìåíåíèÿìè â ïîñëåðîäîâûõ ïëàöåíòàõ.
Äèçàéí èññëåäîâàíèÿ. Îáñëåäîâàíî 30 æåíùèí ñ íåî-
ñëîæíåííûì òå÷åíèåì áåðåìåííîñòè (êîíòðîëüíàÿ ãðóïïà) è
96 æåíùèí ñ ïðèçíàêàìè óãðîçû âûêèäûøà â I òðèìåñòðå
(îñíîâíàÿ ãðóïïà). Èçó÷àëèñü ñûâîðîòî÷íûå óðîâíè áåëêîâ
áåðåìåííîñòè (òðîôîáëàñòè÷åñêîãî â- ãëèêîïðîòåèíà - ÒÁÃ, á-
2-ìèêðîãëîáóëèíà ôåðòèëüíîñòè - ÀÌÃÔ), ãîðìîíîâ êðîâè
(ýñòðàäèîëà, ïðîãåñòåðîíà, êîðòèçîëà) è ïîêàçàòåëè ãåìîñòà-
çà. Äëÿ ëå÷åíèÿ íåâûíàøèâàíèÿ èñïîëüçîâàëè â ñîñòàâå òåðà-
ïåâòè÷åñêîãî êîìïëåêñà ýêñòðàêò ãèíêãî áèëîáà è ýðèíèò.
Ïðîâåäåíî ïàòîãèñòîëîãè÷åñêîå èññëåäîâàíèå ïëàöåíò ïîñëå
ðîäîâ. Â èññëåäîâàíèè èñïîëüçîâàíû ïåðâè÷íûå äàííûå.
Ðåçóëüòàòû. Ýêñòðàêò ãèíêãî áèëîáà è ýðèíèò óëó÷øà-
þò ôóíêöèþ òðîôîáëàñòà â I òðèìåñòðå, à ÒÁÃ è ÀÌÃÔ ÿâ-
ëÿþòñÿ ãëàâíûìè ôàêòîðàìè, ïðåäóïðåæäàþùèìè ðàçâèòèå
íàðóøåíèé â ñèñòåìå ãåìîñòàçà ïðè íåâûíàøèâàíèè. Ñî-
ãëàñíî ðåçóëüòàòàì ïàòîãèñòîëîãèè, ïðåäëîæåííûé òåðàïåâ-
òè÷åñêèé êîìïëåêñ óâåëè÷èâàåò êîìïåíñàòîðíóþ ðåàêöèþ
ïëàöåíòàðíîé òêàíè â îòâåò íà ãèïîêñèþ.
Íîâèçíà. Â èññëåäîâàíèè èçó÷àåòñÿ çíà÷åíèå ïîêàçàòå-
ëåé ïëàöåíòàðíûõ áåëêîâ, ãîðìîíîâ è ïàðàìåòðîâ ãåìîñòà-
çà ó áåðåìåííûõ â êîíòåêñòå óãðîçû âûêèäûøà â ² òðèìåñò-
ðå, â ñîåäèíåíèè ñ ïàòîãèñòîëîãè÷åñêèì èññëåäîâàíèåì
ïëàöåíò ïîñëå ðîäîâ.
Êëþ÷åâûå ñëîâà: óãðîçà âûêèäûøà, òðîôîáëàñò, ïëà-
öåíòà, òðîôîáëàñòè÷åñêèé áåòà-1-ãëèêîïðîòåèí, àëüôà-2-
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